Health care company Abbott Laboratories agreed to settle certain lawsuits that accused the company of knowingly distributing specialty infant formulas that increased the risk of necrotizing enterocolitis (NEC) in preterm babies, a claim the company denies. In order to resolve a portion of the litigation against the firm, it agreed to pay three law firms approximately $670 million to resolve roughly 2,000 cases.
The settlement was made in the Ma…